Viktor Simeonovski

ORCID: 0000-0003-2956-0928
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Indoor Air Quality and Microbial Exposure
  • Skin Protection and Aging
  • Air Quality and Health Impacts
  • Dermatological and COVID-19 studies
  • Autoimmune Bullous Skin Diseases
  • Obesity, Physical Activity, Diet
  • Chronic Myeloid Leukemia Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Cancer and Skin Lesions
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Streptococcal Infections and Treatments
  • Drug-Induced Adverse Reactions
  • Vehicle emissions and performance
  • Allergic Rhinitis and Sensitization
  • melanin and skin pigmentation
  • Essential Oils and Antimicrobial Activity
  • Oral Health Pathology and Treatment
  • Eosinophilic Disorders and Syndromes
  • AI in cancer detection
  • Artificial Intelligence in Healthcare and Education
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Wound Healing and Treatments
  • Birth, Development, and Health
  • Genetic and rare skin diseases.
  • Bee Products Chemical Analysis

Saints Cyril and Methodius University of Skopje
2018-2024

BACKGROUND: In the past several decades, increasing frequency of overweight and obese children adolescents in world has become a public health problem. It contributed significantly to already high tide diabetes, cardiovascular cerebrovascular diseases.AIM: To investigate insulin resistance evaluate metabolic profile resistant non-insulin adolescents.SUBJECTS AND METHODS: The study included 96 (45 boys, 51 girls) aged 4-17 years old (10.50 ± 2.87 years). Only participants with Body Mass Index...

10.3889/oamjms.2018.097 article EN Open Access Macedonian Journal of Medical Sciences 2018-03-14

BACKGROUND: Hydroxyurea (HU) is an antimetabolite agent that interferes with the S-phase of cellular replication and inhibits DNA synthesis, little or no effect on RNA protein synthesis. It used in treatment many myeloproliferative disorders (MD) particularly a first line drug for intermediate to high-risk essential thrombocythemia. Although safe very well tolerated by patients suffering from MD, there have been numerous reports broad palette cutaneous side effects associated prolonged...

10.3889/oamjms.2018.320 article EN Open Access Macedonian Journal of Medical Sciences 2018-08-19

The skin is exposed to numerous particulate and gaseous air pollutants. ones that need particular attention are the particles adhere surface, which can later cause direct damage. This study aimed characterize pollution (AP) adhered human by using scanning electron microscopy (SEM) combined with X-ray dispersive energy spectrometry (EDX).Tape stripping was performed from six healthy volunteers urban AP collect stratum corneum samples cheeks forehead. were analysed SEM equipped EDX system a...

10.1111/jdv.18146 article EN Journal of the European Academy of Dermatology and Venereology 2022-04-12

Acquired lymphangiectasia of the vulva is very uncommon. Owing to non-specific papillomatous manifestation and vast array possible differential diagnoses, lymphangioma circumscriptum (LC) still presents a diagnostic challenge. In this report, we present rare form acquired vulvar LC in 71-year-old patient with longstanding history asymptomatic lesions over labia majora that had been previously treated as genital warts. On examination, multiple clustered translucent papules up 15mm diameter,...

10.5070/d32612051365 article EN cc-by-nc-nd Dermatology Online Journal 2020-01-01

Introduction: Bullous pemphigoid (BP) is an autoimmune skin disease that typically presents with severe itching and blistering, or without eczematous urticarial lesions. Patients BP are at increased risk of comorbid conditions, especially neurologic psychiatric diseases. Several recent studies have found a link between neurological disorders, stroke, dementia, Parkinson's disease. The aim our study was to evaluate the prevalence comorbidities their treatment in patients. Methods: A...

10.5937/afmnai39-35922 article EN Acta Facultatis Medicae Naissensis 2022-01-01
Coming Soon ...